SALIX PHARMACEUTICALS LTD Operating Cash Flow
SALIX PHARMACEUTICALS LTD reported Operating Cash Flow of $4.15 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities for the quarter ending 2013-12-31 was $340.50M.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities for the quarter ending 2013-09-30 was $9.37M, a 85.59% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities for the quarter ending 2013-06-30 was -$145.24M, a 403.50% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities for the quarter ending 2013-03-31 was $211.23M.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities for fiscal 2014 was $4.15M, a 99.00% decline from fiscal 2013.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities for fiscal 2013 was $415.86M, a 374.76% increase from fiscal 2012.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities for fiscal 2012 was $87.59M, a 26.49% decline from fiscal 2011.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities for fiscal 2011 was $119.15M, a 366.93% increase from fiscal 2010.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2014-12-31 | $4.15M 10-K · filed 2015-03-02 | |||
| 2013-12-31 | $340.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $349.87M derived: sum of 2 quarters · filed 2015-03-02 | $204.63M derived: sum of 3 quarters · filed 2015-03-02 | $415.86M 10-K · filed 2015-03-02 |
| 2013-09-30 | $9.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$135.87M derived: sum of 2 quarters · filed 2013-11-08 | $75.36M 10-Q · filed 2013-11-08 | $66.25M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$145.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $65.99M 10-Q · filed 2013-08-09 | $56.88M derived: sum of 3 quarters · filed 2015-03-02 | $121.91M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $211.23M 10-Q · filed 2013-05-10 | $202.12M derived: sum of 2 quarters · filed 2015-03-02 | $267.15M derived: sum of 3 quarters · filed 2015-03-02 | $315.00M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $55.92M derived: sum of 2 quarters · filed 2015-03-02 | $103.78M derived: sum of 3 quarters · filed 2015-03-02 | $87.59M 10-K · filed 2015-03-02 |
| 2012-09-30 | $65.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $112.88M derived: sum of 2 quarters · filed 2013-11-08 | $96.70M 10-Q · filed 2013-11-08 | $170.14M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-06-30 | $47.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $31.67M 10-Q · filed 2013-08-09 | $105.11M derived: sum of 3 quarters · filed 2015-03-02 | $135.58M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-03-31 | -$16.19M 10-Q · filed 2013-05-10 | $57.26M derived: sum of 2 quarters · filed 2015-03-02 | $87.72M derived: sum of 3 quarters · filed 2015-03-02 | $53.98M derived: sum of 4 quarters · filed 2015-03-02 |
| 2011-12-31 | $73.44M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $103.91M derived: sum of 2 quarters · filed 2015-03-02 | $70.16M derived: sum of 3 quarters · filed 2015-03-02 | $119.15M 10-K · filed 2015-03-02 |
| 2011-09-30 | $30.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$3.28M derived: sum of 2 quarters · filed 2012-11-08 | $45.71M 10-Q · filed 2012-11-08 | $68.95M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | -$33.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $15.24M 10-Q · filed 2012-08-09 | $38.48M derived: sum of 3 quarters · filed 2013-03-01 | $70.92M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $48.99M 10-Q · filed 2012-05-08 | $72.23M derived: sum of 2 quarters · filed 2013-03-01 | $104.67M derived: sum of 3 quarters · filed 2013-03-01 | $73.72M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $23.24M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $55.68M derived: sum of 2 quarters · filed 2013-03-01 | $24.73M derived: sum of 3 quarters · filed 2013-03-01 | $25.52M 10-K · filed 2013-03-01 |
| 2010-09-30 | $32.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $1.49M derived: sum of 2 quarters · filed 2011-11-09 | $2.27M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | -$30.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$30.16M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | $784.00K 10-Q · filed 2011-05-10 | |||
| 2009-12-31 | -$56.34M 10-K · filed 2012-02-28 |